Immunopathogenesis and immunotherapy in AIDS virus infections - PubMed (original) (raw)

Review

Immunopathogenesis and immunotherapy in AIDS virus infections

Norman L Letvin et al. Nat Med. 2003 Jul.

Abstract

The heterogeneity of HIV and the different human leukocyte antigen (HLA) backgrounds of infected individuals have posed challenges to understanding the pathogenesis of HIV infection. But continuing advances in our knowledge of the role of immune responses in controlling HIV viremia should help to define goals for immune-based therapies and vaccine strategies against AIDS.

PubMed Disclaimer

Similar articles

• Cytotoxic T-cell recognition of HIV proteins and peptides.
  Nixon DF, McMichael AJ. Nixon DF, et al. AIDS. 1991 Sep;5(9):1049-59. AIDS. 1991. PMID: 1718319 No abstract available.
• Progression of HIV to AIDS: a protective role for HLA-B27?
  den Uyl D, van der Horst-Bruinsma IE, van Agtmael M. den Uyl D, et al. AIDS Rev. 2004 Apr-Jun;6(2):89-96. AIDS Rev. 2004. PMID: 15332431 Review.
• The role of human leukocyte antigen E and G in HIV infection.
  Tripathi P, Agrawal S. Tripathi P, et al. AIDS. 2007 Jul 11;21(11):1395-404. doi: 10.1097/QAD.0b013e32810c8bbc. AIDS. 2007. PMID: 17589185 Review. No abstract available.
• T lymphocyte responses in HIV-1 infection: implications for vaccine development.
  Brander C, Walker BD. Brander C, et al. Curr Opin Immunol. 1999 Aug;11(4):451-9. doi: 10.1016/S0952-7915(99)80076-4. Curr Opin Immunol. 1999. PMID: 10448136 Review.
• The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
  Altfeld M, Allen TM, Kalife ET, Frahm N, Addo MM, Mothe BR, Rathod A, Reyor LL, Harlow J, Yu XG, Perkins B, Robinson LK, Sidney J, Alter G, Lichterfeld M, Sette A, Rosenberg ES, Goulder PJ, Brander C, Walker BD. Altfeld M, et al. J Virol. 2005 Apr;79(8):5000-5. doi: 10.1128/JVI.79.8.5000-5005.2005. J Virol. 2005. PMID: 15795285 Free PMC article.

Cited by

• Professional antigen presenting cells in human herpesvirus 8 infection.
  Knowlton ER, Lepone LM, Li J, Rappocciolo G, Jenkins FJ, Rinaldo CR. Knowlton ER, et al. Front Immunol. 2013 Jan 21;3:427. doi: 10.3389/fimmu.2012.00427. eCollection 2012. Front Immunol. 2013. PMID: 23346088 Free PMC article.
• Memory T cells in the chronic inflammatory microenvironment of nasal polyposis are hyporesponsive to signaling through the T cell receptor.
  Lehman HK, Simpson-Abelson MR, Conway TF Jr, Kelleher RJ Jr, Bernstein JM, Bankert RB. Lehman HK, et al. J Assoc Res Otolaryngol. 2012 Jun;13(3):423-35. doi: 10.1007/s10162-012-0313-8. Epub 2012 Feb 4. J Assoc Res Otolaryngol. 2012. PMID: 22310933 Free PMC article.
• FOXO3 regulates the CD8 T cell response to a chronic viral infection.
  Sullivan JA, Kim EH, Plisch EH, Suresh M. Sullivan JA, et al. J Virol. 2012 Sep;86(17):9025-34. doi: 10.1128/JVI.00942-12. Epub 2012 Jun 6. J Virol. 2012. PMID: 22675000 Free PMC article.
• Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles.
  Kwon YJ, Standley SM, Goh SL, Fréchet JM. Kwon YJ, et al. J Control Release. 2005 Jul 20;105(3):199-212. doi: 10.1016/j.jconrel.2005.02.027. J Control Release. 2005. PMID: 15935507 Free PMC article.
• Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames.
  Cardinaud S, Moris A, Février M, Rohrlich PS, Weiss L, Langlade-Demoyen P, Lemonnier FA, Schwartz O, Habel A. Cardinaud S, et al. J Exp Med. 2004 Apr 19;199(8):1053-63. doi: 10.1084/jem.20031869. Epub 2004 Apr 12. J Exp Med. 2004. PMID: 15078897 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program